BACKGROUND: Metabolic adaptation and maladaptation are hallmarks of the failing heart and may be a target for therapeutic ...

Unless otherwise noted, all growth rates in this Release refer to same period in prior year. 2. Please see detailed guidance ...

A new research paper was published in Volume 18 of Aging on July 6, 2026, titled "Inhibition of peroxisomal protein PRX-11 ...

Eleven new molecular drug targets receive approval in 2025, expanding treatment options for rare diseases, cancer, and infectious diseases.

IgA nephropathy (IgAN), the most common primary glomerulonephritis worldwide, has an estimated incidence of 0.2-5 per 100,000 ...

Researchers ranked 83 preclinical candidates for preventing or treating preeclampsia and eclampsia, identifying 11 as having ...

People online are using it to supercharge their metabolism and potentially extend their lifespan.

Researchers ranked 11 preeclampsia therapy candidates as high-potential, but evidence gaps, safety concerns and limited ...

Background Circulatory collapse at hospital arrival represents one of the most severe clinical presentations of ST-segment ...

Remix Therapeutics (Remix), Inc., a clinical-stage biotechnology company developing small molecule therapies to modulate RNA processing and address the underlying drivers of disease, today announced ...

A lattice-like scaffold hidden inside neurons acts as a spatial gatekeeper for how brain cells absorb material from their ...

House Problem-Solvers Caucus breakfast group (consisting of PSC co-chairs and 16 non-profit leaders) received today ? from Center for Collaborative Democracy CEO Sol Erdman ?  an invitation to turn ...